Cargando…

Impacts of the SOAT1 genetic variants and protein expression on HBV-related hepatocellular carcinoma

BACKGROUND: Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) remains a major public health problem and its pathogenesis remains unresolved. A recent proteomics study discovered a lipid enzyme Sterol O-acyltransferase (SOAT1) involvement in the progression of HCC. We aimed to explore th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yulong, Yang, Xunjun, Chen, Yao, Chen, Guorong, Winkler, Cheryl A., An, Ping, Lyu, Jianxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152151/ https://www.ncbi.nlm.nih.gov/pubmed/34039309 http://dx.doi.org/10.1186/s12885-021-08245-1

Ejemplares similares

Telomerase reverse transcriptase promoter mutations in hepatitis B virus-associated hepatocellular carcinoma
por: Yang, Xunjun, et al.
Publicado: (2016)

Host and Viral Genetic Variation in HBV-Related Hepatocellular Carcinoma
por: An, Ping, et al.
Publicado: (2018)

SOAT1 missense variant in two cats with sebaceous gland dysplasia
por: Kiener, Sarah, et al.
Publicado: (2023)

Simultaneously targeting SOAT1 and CPT1A ameliorates hepatocellular carcinoma by disrupting lipid homeostasis
por: Ren, Meiling, et al.
Publicado: (2021)

SOAT1 methylation is associated with coronary heart disease
por: Abuzhalihan, Jialin, et al.
Publicado: (2019)

Association of the GLB1 rs4678680 genetic variant with risk of HBV-related hepatocellular carcinoma
por: Wang, Wen-Tao, et al.
Publicado: (2016)

The Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) Pathogenesis
por: Sartorius, Kurt, et al.
Publicado: (2019)

A Genetic Variant in Long Non-Coding RNA HULC Contributes to Risk of HBV-Related Hepatocellular Carcinoma in a Chinese Population
por: Liu, Yao, et al.
Publicado: (2012)

Potentially Functional Genetic Variants in the NRF2 Signaling Pathway Genes are Associated With HBV-related Hepatocellular Carcinoma Survival
por: Gong, Rongbin, et al.
Publicado: (2023)

A Genetic Variant in the Promoter Region of miR-106b-25 Cluster and Risk of HBV Infection and Hepatocellular Carcinoma
por: Liu, Yao, et al.
Publicado: (2012)

Impact of MAFLD on the complications after hepatectomy in patients with HBV-related hepatocellular carcinoma
por: Xiong, Ke-Gong, et al.
Publicado: (2023)

Prognostic value of integrin variants and expression in post-operative patients with HBV-related hepatocellular carcinoma
por: Shang, Liming, et al.
Publicado: (2017)

HBV genome-enriched single cell sequencing revealed heterogeneity in HBV-driven hepatocellular carcinoma (HCC)
por: Wang, Wenhui, et al.
Publicado: (2022)

SOAT1 Promotes Gastric Cancer Lymph Node Metastasis Through Lipid Synthesis
por: Zhu, Tingting, et al.
Publicado: (2021)

Germline Variants and Genetic Interactions of Several EMT Regulatory Genes Increase the Risk of HBV-Related Hepatocellular Carcinoma
por: Liu, Wen-Xuan, et al.
Publicado: (2021)

Efficacy of olmesartan amlodipine in Colombian hypertensive patients (soat study)
por: Buendia, Richard, et al.
Publicado: (2017)

SOAT1 promotes mevalonate pathway dependency in pancreatic cancer
por: Oni, Tobiloba E., et al.
Publicado: (2020)

The HBV Specially-Related Long Noncoding RNA HBV-SRL Involved in the Pathogenesis of Hepatocellular Carcinoma
por: Zhang, Cunzhen, et al.
Publicado: (2022)

SAT-354 Characterization of Cell Death Induced by SOAT1 Inhibition in Adrenocortical Carcinoma Cells
por: Weigand, Isabel, et al.
Publicado: (2019)

Fine Mapping of the MHC Region Identifies Novel Variants Associated with HBV-Related Hepatocellular Carcinoma in Han Chinese
por: Mai, Haoming, et al.
Publicado: (2021)

HBV integrated genomic characterization revealed hepatocyte genomic alterations in HBV-related hepatocellular carcinomas
por: Yang, Ming, et al.
Publicado: (2020)

Association between Recipient IL-15 Genetic Variant and the Prognosis of HBV-Related Hepatocellular Carcinoma after Liver Transplantation
por: Zhang, Tao, et al.
Publicado: (2017)

FXYD6 overexpression in HBV-related hepatocellular carcinoma with cirrhosis
por: Chen, Xiongfei, et al.
Publicado: (2020)

Genetic variations of NTCP are associated with susceptibility to HBV infection and related hepatocellular carcinoma
por: Wang, Peng, et al.
Publicado: (2017)

Leukocyte Telomere Length-Related rs621559 and rs398652 Genetic Variants Influence Risk of HBV-Related Hepatocellular Carcinoma
por: Pan, Wenting, et al.
Publicado: (2014)

Ferroptosis sensitization in glioma: exploring the regulatory mechanism of SOAT1 and its therapeutic implications
por: Sun, Shicheng, et al.
Publicado: (2023)

Application and Impact of Antiviral Therapy for Patients with HBV-Related Hepatocellular Carcinoma Receiving Sorafenib and Lenvatinib Treatment
por: Lee, I-Cheng, et al.
Publicado: (2022)

Impact of MAFLD on HBV-Related Stage 0/A Hepatocellular Carcinoma after Curative Resection
por: Lin, Yen-Po, et al.
Publicado: (2021)

Genetic variants in pseudogene E2F3P1 confer risk for HBV-related hepatocellular carcinoma in a Chinese population
por: Liu, Li, et al.
Publicado: (2013)

Association of HBV DNA replication with antiviral treatment outcomes in the patients with early-stage HBV-related hepatocellular carcinoma undergoing curative resection
por: Chen, Jian-Lin, et al.
Publicado: (2016)

Impact of antiviral therapy with nucleos(t)ide analog on survival of patients with HBV-related small hepatocellular carcinomas
por: Wei, Yanyan, et al.
Publicado: (2019)

The impact of thrombocytopenia on prognosis of HBV-related small hepatocellular carcinoma: a propensity score matching analysis
por: Peng, Wei, et al.
Publicado: (2021)

Comprehensive investigation of cytokine- and immune-related gene variants in HBV-associated hepatocellular carcinoma patients
por: Yu, Fengxue, et al.
Publicado: (2017)

The Mechanisms of HBV-Induced Hepatocellular Carcinoma
por: Jiang, Yu, et al.
Publicado: (2021)

Circulating circRNA predicting the occurrence of hepatocellular carcinoma in patients with HBV infection
por: Wu, Chen, et al.
Publicado: (2020)

The Role of Antiviral Therapy for HBV-Related Hepatocellular Carcinoma
por: Yu, Liang-He, et al.
Publicado: (2011)

SOAT1: A Suitable Target for Therapy in High-Grade Astrocytic Glioma?
por: Löhr, Mario, et al.
Publicado: (2022)

A pan-cancer analysis identifies SOAT1 as an immunological and prognostic biomarker
por: HUANG, YANGQING, et al.
Publicado: (2023)

Iron-sulphur cluster biogenesis factor LYRM4 is a novel prognostic biomarker associated with immune infiltrates in hepatocellular carcinoma
por: Pang, Yilin, et al.
Publicado: (2021)

The Multiple Roles of Hepatitis B Virus X Protein (HBx) Dysregulated MicroRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) and Immune Pathways
por: Sartorius, Kurt, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_me9k5i5nu67cn4nr1bb8bq1ieb